• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从关怀到治愈:展示针对高需求患者丙型肝炎护理与治疗的临床患者导航模式

From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients.

作者信息

Ford Mary M, Johnson Nirah, Desai Payal, Rude Eric, Laraque Fabienne

机构信息

Bureau of Communicable Disease, New York City Department of Health and Mental Hygiene, Long Island City, New York, USA.

出版信息

Clin Infect Dis. 2017 Mar 1;64(5):685-691. doi: 10.1093/cid/ciw806. Epub 2016 Dec 10.

DOI:10.1093/cid/ciw806
PMID:27940945
Abstract

The NYC Department of Health implemented a patient navigation program, Check Hep C, to address patient and provider barriers to HCV care and potentially lifesaving treatment. Services were delivered at two clinical care sites and two sites that linked patients to off-site care. Working with a multidisciplinary care team, patient navigators provided risk assessment, health education, treatment readiness and medication adherence counseling, and medication coordination. Between March 2014 and January 2015, 388 participants enrolled in Check Hep C, 129 (33%) initiated treatment, and 119 (91% of initiators) had sustained virologic response (SVR). Participants receiving on-site clinical care had higher odds of initiating treatment than those linked to off-site care. Check Hep C successfully supported high-need participants through HCV care and treatment, and SVR rates demonstrate the real-world ability of achieving high cure rates using patient navigation care models.

摘要

纽约市卫生部门实施了一项患者导航计划“检查丙肝”,以消除患者和医疗服务提供者在丙肝护理及可能挽救生命的治疗方面面临的障碍。服务在两个临床护理点以及两个将患者与外部护理联系起来的地点提供。患者导航员与多学科护理团队合作,提供风险评估、健康教育、治疗准备和药物依从性咨询以及药物协调。在2014年3月至2015年1月期间,388名参与者加入了“检查丙肝”计划,129人(33%)开始治疗,其中119人(占开始治疗者的91%)实现了持续病毒学应答(SVR)。接受现场临床护理的参与者开始治疗的几率高于那些与外部护理有联系的参与者。“检查丙肝”计划通过丙肝护理和治疗成功地为有高需求的参与者提供了支持,SVR率表明了使用患者导航护理模式在现实世界中实现高治愈率的能力。

相似文献

1
From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients.从关怀到治愈:展示针对高需求患者丙型肝炎护理与治疗的临床患者导航模式
Clin Infect Dis. 2017 Mar 1;64(5):685-691. doi: 10.1093/cid/ciw806. Epub 2016 Dec 10.
2
Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.检查丙型肝炎:一种基于社区的丙型肝炎诊断及高危人群护理衔接方法。
J Public Health Manag Pract. 2018 Jan/Feb;24(1):41-48. doi: 10.1097/PHH.0000000000000519.
3
Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.一项基于社区、聚焦特定地理区域的丙型肝炎病毒(HCV)筛查、治疗衔接及患者导航项目的结果
J Gen Intern Med. 2015 Jul;30(7):950-7. doi: 10.1007/s11606-015-3209-6. Epub 2015 Feb 14.
4
Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse.综合关怀提高了慢性丙型肝炎病毒感染合并精神疾病或物质滥用患者的治疗效果和改善了其预后。
Clin Gastroenterol Hepatol. 2015 Nov;13(11):2005-14.e1-3. doi: 10.1016/j.cgh.2015.02.022. Epub 2015 Feb 24.
5
Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs.远程医疗专业支持促进退伍军人事务部初级保健提供者治疗丙型肝炎。
Am J Med. 2017 Apr;130(4):432-438.e3. doi: 10.1016/j.amjmed.2016.11.019. Epub 2016 Dec 18.
6
Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimens.医疗服务提供者类型对基于博赛泼维及基于特拉泼维方案的丙型肝炎治疗结果的影响。
J Clin Gastroenterol. 2015 Apr;49(4):329-35. doi: 10.1097/MCG.0000000000000124.
7
Virological response of Tunisians patients treated by peginterferon plus ribavirin for chronic hepatitis C: a preliminary study.聚乙二醇干扰素联合利巴韦林治疗突尼斯慢性丙型肝炎患者的病毒学反应:一项初步研究。
Tunis Med. 2008 Apr;86(4):341-5.
8
Use of specialty care versus standard retail pharmacies for treatment of hepatitis C.使用专科护理机构与标准零售药店治疗丙型肝炎的情况。
Ann Pharmacother. 2009 Feb;43(2):202-9. doi: 10.1345/aph.1L227. Epub 2009 Feb 3.
9
Beyond viral response: A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support.超越病毒学应答:一项基于社区的、多学科、同伴驱动的 HCV 治疗和支持模式的前瞻性评估。
Int J Drug Policy. 2015 Oct;26(10):1007-13. doi: 10.1016/j.drugpo.2015.04.012. Epub 2015 Apr 29.
10
Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.慢性丙型肝炎病毒感染者的识别和临床管理 - 切罗基族,2012-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):461-6. doi: 10.15585/mmwr.mm6518a2.

引用本文的文献

1
Hepatitis C Care in the Greater New Orleans Area: Patient Perspectives on the Barriers and Facilitators to Care.大新奥尔良地区的丙型肝炎护理:患者对护理障碍和促进因素的看法。
J Health Care Poor Underserved. 2025;36(1):257-283. doi: 10.1353/hpu.2025.a951596.
2
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder.移动健康激励依从性加患者导航(MIAPP):一项试点随机对照试验的方案,旨在改善甲基苯丙胺使用和阿片类药物使用障碍住院患者丁丙诺啡的联系和维持治疗。
Addict Sci Clin Pract. 2025 Jan 29;20(1):6. doi: 10.1186/s13722-025-00538-1.
3
Financial incentives to motivate treatment for hepatitis C with direct acting antivirals among Australian adults (The Methodical evaluation and Optimisation of Targeted IncentiVes for Accessing Treatment of Early-stage hepatitis C: MOTIVATE-C): protocol for a dose-response randomised controlled study.
经济激励措施以激励澳大利亚成年人使用直接作用抗病毒药物治疗丙型肝炎(方法学评估和优化针对早期丙型肝炎治疗的靶向激励措施:MOTIVATE-C):一项剂量反应随机对照研究方案。
Trials. 2024 Jun 17;25(1):387. doi: 10.1186/s13063-024-08212-8.
4
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.在临床实践中 HIV/HCV 合并感染患者对 glecaprevir/pibrentasvir 的应答反应。
J Antimicrob Chemother. 2023 Oct 3;78(10):2591-2596. doi: 10.1093/jac/dkad278.
5
Hepatitis C Cascades: Data to Inform Hepatitis C Elimination in the United States.丙型肝炎传播链:为美国消除丙型肝炎提供信息的数据。
Public Health Rep. 2023 Sep 5:333549231193508. doi: 10.1177/00333549231193508.
6
Development, implementation, and feasibility of site-specific hepatitis C virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study - a prospective single-arm intervention trial.针对弱势高危人群的特定场所丙型肝炎病毒治疗工作流程的开发、实施及可行性:消除丙肝研究方案——一项前瞻性单臂干预试验
Pilot Feasibility Stud. 2023 May 8;9(1):78. doi: 10.1186/s40814-023-01311-4.
7
Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.“PrEP for Health”干预措施提高注射吸毒人群中 HIV 预防用药使用的疗效试验研究方案
BMC Public Health. 2023 Mar 17;23(1):513. doi: 10.1186/s12889-023-15429-w.
8
Impact of an Accelerated Pretreatment Evaluation on Linkage-to-Care for Hepatitis C-infected Persons Who Inject Drugs.加速预处理评估对丙型肝炎感染的注射吸毒者获得治疗的影响。
Subst Abuse. 2022 Aug 12;16:11782218221119068. doi: 10.1177/11782218221119068. eCollection 2022.
9
The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?预防策略在加拿大实现丙型肝炎病毒消除中的作用:尚存哪些挑战?
Can Liver J. 2018 Jul 17;1(2):4-13. doi: 10.3138/canlivj.1.2.003. eCollection 2018 Spring.
10
Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial.为注射毒品的年轻人快速启动丙型肝炎治疗:寻求、检测和快速治疗随机试验
Open Forum Infect Dis. 2022 May 7;9(7):ofac225. doi: 10.1093/ofid/ofac225. eCollection 2022 Jul.